Impella temporary pump for end-stage heart failure
Part of Heart & circulation clinical trials.
This study tests whether using a temporary heart pump called Impella 5.5 can help strengthen a very weak and enlarged heart (dilated cardiomyopathy) in people who are waiting for a heart transplant. If you qualify, the pump is placed to support your heart temporarily, and the research team will check how your heart responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have dilated cardiomyopathy (enlarged, weak heart) with specific measurements: your heart's main pumping chamber is larger than 5.5 cm and your ejection fraction (pumping strength) is below 25%.
- Your doctor plans to use a temporary heart pump called Impella 5.5 to help your heart while you wait for a heart transplant or a decision about transplant.
- You have NOT had a balloon pump for more than 7 days or any other temporary heart support device before the Impella is placed.
- You do NOT have other major heart conditions like congenital heart disease, certain types of cardiomyopathy (hypertrophic, restrictive, or from sarcoidosis/amyloidosis), or a recent heart muscle infection, and you do not have a mechanical heart valve, blood clots in your heart, or severe artery disease that would make the pump unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special heart pump (Impella 5.5) can help patients with severe heart failure (cardiogenic shock) safely start and increase their heart failure medications. The goal is to see if this approach can help the heart recover and improve outcomes.
This study looks at used Impella heart pumps to see what deposits build up on them during treatment. If you've had an Impella pump for a certain length of time, this study helps doctors learn more about the device.
This trial is testing whether a temporary heart pump (Impella) can help people with severe heart failure and cardiogenic shock (when the heart can't pump enough blood). The goal is to see if this device can reduce fluid buildup and improve blood flow, but it's for people who are very ill and need extra support.
This study tests whether using a special heart pump (called Impella) during a high-risk procedure to open blocked heart arteries can help protect your heart. It aims to see if this support improves the success and safety of the procedure in people with weak hearts.
This trial tests whether switching to a more powerful heart pump (Impella 5.5) within 24 hours of a heart attack helps people whose hearts are still struggling despite a standard pump. It may be an option for patients who had a heart attack, received an Impella CP pump, but still need strong medication to keep blood flowing.
This study looks at using a temporary heart pump called Impella ECP during planned high-risk heart stent procedures (PCI). It may help doctors support the heart more safely while placing the stents.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.